Acceptability of Naloxone Dispensing Among Pharmacists.
Acceptability of Naloxone Dispensing Among Pharmacists.
复制标题
DOI:
10.1177/0897190018798465
复制
发表时间:
2020-06
影响因子:
1.3
通讯作者:
Coffin P
中科院分区:
文献类型:
--
作者:
Do V;Behar E;Turner C;Geier M;Coffin P
Addressing the opioid epidemic requires participation from the entire healthcare system, including pharmacists. The San Francisco Department of Public Health initiated naloxone prescribing at six safety net clinics. We evaluated this intervention, demonstrating that naloxone prescribing from primary care clinics is feasible and acceptable. To evaluate acceptability of naloxone dispensing to patients prescribed opioids among pharmacists serving clinics participating in a naloxone intervention. We surveyed 58 pharmacists at pharmacies that serviced San Francisco safety net clinics. In-person surveys collected information on demographics, experiences in dispensing naloxone, and interest in prescriptive authority. Surveys were completed November 2013 through January 2015. We conducted descriptive analyses and assessed bivariate relationships. Most respondents were staff (56.9%) or supervising pharmacists (34.5%). Most (92.9%) were aware their pharmacy stocked naloxone and 86.8% felt it should be prescribed to some or all patients on long-term opioids. Most (82.1%) dispensed naloxone at least once in the past 12 months. More than half were comfortable providing naloxone education. Nearly half (43.4%) indicated they would want authority to furnish without a prescription. Over half (55.2%) reported no problems dispensing. The common problem was lack of sufficient naloxone knowledge. Only 12% reported more than one problem in dispensing naloxone to patients, which was associated with being uncomfortable with educating patients (p=0.03). Naloxone dispensing was acceptable among pharmacists. Their most cited problem was lack of sufficient naloxone education. This may be resolved with improved instructional materials, incentives for extensive patient education, or mandatory training.
登录
查看更多内容
DOI:
10.1007/s11524-015-9967-y
发表时间:
2015-08-01
影响因子:
6.6
作者:
Visconti, Adam J.;Santos, Glenn-Milo;Coffin, Phillip O.
通讯作者:
Coffin, Phillip O.
影响因子:
6
作者:
Nielsen, Suzanne;Menon, Nadia;Degenhardt, Louisa
通讯作者:
Degenhardt, Louisa
DOI:
10.1016/j.japh.2016.12.070
发表时间:
2017-03-01
影响因子:
2.1
作者:
Thornton, J. Douglas;Lyvers, Elizabeth;Dwibedi, Nilanjana
通讯作者:
Dwibedi, Nilanjana
DOI:
10.1136/bmj.f174
发表时间:
2013-01-30
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Walley AY;Xuan Z;Hackman HH;Quinn E;Doe-Simkins M;Sorensen-Alawad A;Ruiz S;Ozonoff A
通讯作者:
Ozonoff A